Oxaliplatin Kabi 5 mg/ml Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

oxaliplatin kabi 5 mg/ml

fresenius kabi s.r.o., Česká republika - oxaliplatina - 44 - cytostatica

Teysuno Európska únia - slovenčina - EMA (European Medicines Agency)

teysuno

nordic group b.v. - tegafur, gimeracil, oteracil - neoplazmy žalúdka - antineoplastické činidlá - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Senshio Európska únia - slovenčina - EMA (European Medicines Agency)

senshio

shionogi b.v. - ospemifen - postmenopause - pohlavné hormóny a modulátory z genitálny systém, - senshio is indicated for the treatment of moderate to severe symptomatic vulvar and vaginal atrophy (vva) in post-menopausal women.